In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Venture Capitalists Step Up Investment in Services

Executive Summary

As products from technology-driven start-ups increasingly fail to gain support from customers and investors, VCs are steering more of their life sciences funds towards services. The withdrawal from technology , however, is more like a fire drill than a stampede, owing to the non-proprietary nature of medical service businesses. Yet the inefficiencies in US health care beg for solutions and VCs plan to oblige--largely by proferring information systems.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

IV000096

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel